Rachid Izzar - 08 Feb 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Global Product Strat.
Signature
/s/ Wendell Taylor, attorney-in-fact for Rachid Izzar
Issuer symbol
BIIB
Transactions as of
08 Feb 2023
Net transactions value
$0
Form type
4
Filing time
10 Feb 2023, 17:47:17 UTC
Previous filing
27 Jan 2023
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIIB Common Stock 4,844 08 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Award $0 +6,130 $0.000000 6,130 08 Feb 2023 Common Stock 6,130 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.